Encouraging results may lead to effective treatments for a range of rare syndromes that impair brain functions.

Tel Aviv University researchers have discovered a mechanism shared by mutations in two specific genes which cause autism, schizophrenia, and other conditions. They also found that an experimental drug is effective in lab models for these mutations and may be suitable for treating a range of rare syndromes that impair brain functions.

As reported by TPS
Image source: Shutterstock